Skip to main content

Dihydroergotamine Mesylate Nasal

NDC 69097-503 · Cipla USA Inc.

Generic nameDihydroergotamine Mesylate Nasal
Dosage formSPRAY, METERED
RouteNASAL
Active ingredient(s)DIHYDROERGOTAMINE MESYLATE
Strength4 mg/mL
Pharmacologic classErgotamine Derivative [EPC], Ergotamines [CS]
Marketing categoryANDA

Packages

69097-503-27 — 8 VIAL in 1 KIT (69097-503-27) / 1 mL in 1 VIAL

69097-503-31 — 1 VIAL in 1 KIT (69097-503-31) / 1 mL in 1 VIAL

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9151 — Dihydroergotamine Mesylate, 0143-9273 — Dihydroergotamine Mesylate, 24201-463 — Dihydroergotamine Mesylate, 36000-300 — dihydroergotamine mesylate, 64896-509 — Dihydroergotamine Mesylate, 68083-466 — Dihydroergotamine Mesylate, 68682-357 — dihydroergotamine mesylate, 70069-880 — DIHYDROERGOTAMINE MESYLATE, 71357-013 — Dihydroergotamine Mesylate, 72888-096 — Dihydroergotamine mesylate, 73352-096 — Dihydroergotamine mesylate, 76978-101 — DIHYDROERGOTAMINE MESYLATE, 77530-725 — Dihydroergotamine mesylate, 81284-411 — Dihydroergotamine Mesylate

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels